Skip to content

Pharmacy

CVS drug disposal program makes impact

CVS drug disposal program makes impact

CVS Health has collected more than 47 metric tons of expired, unused and unwanted drugs through its Medication Disposal for Safer Communities program. CVS said Thursday that it has has donated 626 safe drug disposal boxes to police departments in 42 states since launching the program in 2014.

Savings from generic drugs edge up

Savings from generic drugs edge up

Annual health care savings from generic prescription drugs rose nearly 10% last year to $227 billion, according to the Generic Pharmaceutical Association (GPhA).

Walgreens hits mark in safe medication disposal

Walgreens hits mark in safe medication disposal

Walgreens has hit its target in fostering proper disposal of expired, unwanted and unused medications. The drug chain said Tuesday that it has reached its goal of installing more than 500 safe medication disposal kiosks this year at its pharmacies in 35 states and Washington, D.C.

CVS lends hand with Medicare Part D enrollment

CVS lends hand with Medicare Part D enrollment

With open enrollment for Medicare Part D kicking off over the weekend, CVS Pharmacy has begun offering in-store and online resources to help seniors select prescription drug coverage for the 2017 plan year.

Teva releases Rajani birth control pill

Teva releases Rajani birth control pill

Teva Pharmaceutical Industries Ltd. has launched Rajani, an oral contraceptive, to pharmacies in the United States. Teva said Wednesday that Rajani (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.02 mg/0.451 mg, and levomefolate calcium tablets, 0.

Report: Amazon plans convenience food stores

Report: Amazon plans convenience food stores

Amazon.com Inc. reportedly plans to boost its grocery business by opening small brick-and-mortar stores. The outlets would sell perishable items such as milk, meat and produce, according to The Wall Street Journal, which cited anonymous sources familiar with retailer’s intentions.

Mylan to pay $465 million in EpiPen settlement

Mylan to pay $465 million in EpiPen settlement

Mylan N.V. has agreed to pay $465 million to the U.S. Department of Justice and other government agencies to resolve discrepancies about the classification of the EpiPen epinephrine auto-injector in the Medicaid Drug Rebate Program.